Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesDec 27, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 21, 2012View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventDec 18, 2012View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesDec 17, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 14, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 13, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 12, 2012View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GDec 11, 2012View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesDec 11, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 6, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 3, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 30, 2012View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventNov 28, 2012View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesNov 26, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 19, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 19, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 19, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 19, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 15, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 14, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 14, 2012View HTMLDownload DOCDownload PDF
3Initial filing by director officer or owner of more than ten percent.Nov 13, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 13, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 9, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 9, 2012View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-125      126-150      151-154

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information